Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Silk Road MedicalPulmonxAxonics Modulation TechnologiesCardiovascular SystemsInovio Pharmaceuticals
SymbolNASDAQ:SILKNASDAQ:LUNGNASDAQ:AXNXNASDAQ:CSIINASDAQ:INO
Price Information
Current Price$50.14$43.48$60.13$36.13$8.72
52 Week RangeBuyBuyBuyBuyHold
MarketRank™
Overall Score1.11.41.31.71.4
Analysis Score2.34.31.53.53.1
Community Score2.42.22.82.63.0
Dividend Score0.00.00.00.00.0
Ownership Score0.00.01.71.70.8
Earnings & Valuation Score0.60.60.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$61.75$58.00$64.25$47.57$17.00
% Upside from Price Target23.16% upside33.39% upside6.85% upside31.67% upside94.95% upside
Trade Information
Market Cap$1.72 billion$1.55 billion$2.50 billion$1.45 billion$1.82 billion
Beta1.41N/A0.021.191.08
Average Volume380,925251,941573,461214,83714,070,765
Sales & Book Value
Annual Revenue$63.35 million$32.60 million$13.82 million$236.54 million$4.11 million
Price / Sales27.2047.60180.666.14441.95
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.33 per shareN/A$6.40 per share$7.62 per share$0.05 per share
Price / Book21.529.404.74174.40
Profitability
Net Income$-52,420,000.00$-20,700,000.00$-79,930,000.00$-27,240,000.00$-119,360,000.00
EPS($1.36)N/A($2.80)($0.79)($1.16)
Trailing P/E RatioN/A0.00N/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-53.66%N/A-76.62%-10.12%-8,518.10%
Return on Equity (ROE)-40.79%N/A-28.05%-11.43%-78.17%
Return on Assets (ROA)-24.56%N/A-23.44%-8.36%-40.33%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.38%N/A0.02%0.08%0.17%
Current Ratio11.80%3.67%8.62%6.25%9.14%
Quick Ratio11.08%3.05%7.48%5.61%9.14%
Ownership Information
Institutional Ownership PercentageN/AN/A84.23%89.70%35.96%
Insider Ownership Percentage7.80%N/A25.74%3.00%4.00%
Miscellaneous
Employees281220416779262
Shares Outstanding34.37 million35.69 million41.52 million40.19 million208.31 million
Next Earnings Date4/29/2021 (Estimated)6/1/2021 (Estimated)5/4/2021 (Estimated)5/4/2021 (Estimated)5/10/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableOptionable
SourceHeadline
INOVIO INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of InoINOVIO INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Ino
us.acrofan.com - April 10 at 6:26 AM
INOVIO INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inovio Pharmaceuticals Inc. - INOINOVIO INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inovio Pharmaceuticals Inc. - INO
finance.yahoo.com - April 10 at 6:26 AM
Inovio Pharmaceuticals Charts Are Not EncouragingInovio Pharmaceuticals Charts Are Not Encouraging
finance.yahoo.com - April 9 at 12:41 PM
Global Needle Free Drug Delivery Device Market 2020 | Price Trends, Industry Overview, Growth and Forecast till 2025Global Needle Free Drug Delivery Device Market 2020 | Price Trends, Industry Overview, Growth and Forecast till 2025
marketwatch.com - April 6 at 1:33 PM
Inovio Pharmaceuticals Stock Is Estimated To Be Fairly ValuedInovio Pharmaceuticals Stock Is Estimated To Be Fairly Valued
finance.yahoo.com - April 5 at 7:05 PM
This 1 Element May Be Holding Inovios Vaccine BackThis 1 Element May Be Holding Inovio's Vaccine Back
finance.yahoo.com - April 2 at 8:36 AM
Inovio Pharmaceuticals (NASDAQ:INO) Now Covered by Analysts at Bank of AmericaInovio Pharmaceuticals (NASDAQ:INO) Now Covered by Analysts at Bank of America
americanbankingnews.com - March 29 at 10:02 AM
Bank of America Initiates Coverage on Inovio Pharmaceuticals (NASDAQ:INO)Bank of America Initiates Coverage on Inovio Pharmaceuticals (NASDAQ:INO)
marketbeat.com - March 29 at 8:51 AM
Inovio VGX-3100 HPV Data Adds To ConvictionInovio VGX-3100 HPV Data Adds To Conviction
seekingalpha.com - March 25 at 7:36 PM
Interesting INO Put And Call Options For May 7thInteresting INO Put And Call Options For May 7th
nasdaq.com - March 25 at 7:36 PM
For Inovio Pharmaceuticals Inc. [INO], Analyst sees a rise to $13. What next?For Inovio Pharmaceuticals Inc. [INO], Analyst sees a rise to $13. What next?
dbtnews.com - March 25 at 2:35 PM
Montco Biopharma Company Working On Vaccine For COVID VariantsMontco Biopharma Company Working On Vaccine For COVID Variants
patch.com - March 24 at 6:07 PM
Inovio Pharmaceuticals Stock Shows Every Sign Of Being Fairly ValuedInovio Pharmaceuticals Stock Shows Every Sign Of Being Fairly Valued
news.yahoo.com - March 24 at 6:07 PM
Down 40% From Recent Highs Can Inovio Pharmaceuticals Stock Rebound?Down 40% From Recent Highs Can Inovio Pharmaceuticals Stock Rebound?
forbes.com - March 24 at 8:05 AM
Global Vaccines Market Size 2021 | To Hit USD 93.08 Billion with 10.7% CAGR by 2026Global Vaccines Market Size 2021 | To Hit USD 93.08 Billion with 10.7% CAGR by 2026
marketwatch.com - March 23 at 9:55 AM
Bank of America Begins Coverage on Inovio Pharmaceuticals (NASDAQ:INO)Bank of America Begins Coverage on Inovio Pharmaceuticals (NASDAQ:INO)
americanbankingnews.com - March 23 at 8:22 AM
Vaxart or Inovio: Which Is More Likely to Double Your Money?Vaxart or Inovio: Which Is More Likely to Double Your Money?
finance.yahoo.com - March 21 at 8:59 AM
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Given Average Rating of "Hold" by BrokeragesInovio Pharmaceuticals, Inc. (NASDAQ:INO) Given Average Rating of "Hold" by Brokerages
americanbankingnews.com - March 21 at 2:46 AM
These 3 Vaccine Stocks May Be Post-Pandemic WinnersThese 3 Vaccine Stocks May Be Post-Pandemic Winners
finance.yahoo.com - March 20 at 8:34 AM
Inovio Pharmaceuticals (NASDAQ:INO)  Shares Down 6.5% Inovio Pharmaceuticals (NASDAQ:INO) Shares Down 6.5%
americanbankingnews.com - March 18 at 7:42 PM
Global Zika Vaccines Market Size 2021 Global Industry Share, Revenue, Business Growth, Demand and Applications Market Research Report to 2027Global Zika Vaccines Market Size 2021 Global Industry Share, Revenue, Business Growth, Demand and Applications Market Research Report to 2027
marketwatch.com - March 18 at 12:20 PM
Companies Collaborate to Develop Companion Diagnostic for Immunotherapy in HPV-Associated Cervical DysplasiaCompanies Collaborate to Develop Companion Diagnostic for Immunotherapy in HPV-Associated Cervical Dysplasia
onclive.com - March 18 at 12:20 PM
Caliber Associates Recruits General Counsel for INOVIO PharmaceuticalsCaliber Associates Recruits General Counsel for INOVIO Pharmaceuticals
huntscanlon.com - March 18 at 12:20 PM
Head to Head Review: Obalon Therapeutics (NASDAQ:OBLN) vs. Inovio Pharmaceuticals (NASDAQ:INO)Head to Head Review: Obalon Therapeutics (NASDAQ:OBLN) vs. Inovio Pharmaceuticals (NASDAQ:INO)
americanbankingnews.com - March 17 at 2:48 AM
Hiv Vaccine Market to Eyewitness Massive Growth by 2027 : Sanofi, Geovax, GenecureHiv Vaccine Market to Eyewitness Massive Growth by 2027 : Sanofi, Geovax, Genecure
sbwire.com - March 16 at 12:09 AM
INOVIO Announces the Appointment of Michael Cordera As Executive Vice President & General CounselINOVIO Announces the Appointment of Michael Cordera As Executive Vice President & General Counsel
finance.yahoo.com - March 15 at 8:09 AM
How to Invest After a Turbulent 2020 Election (INO)How to Invest After a Turbulent 2020 Election (INO)
marketbeat.com - November 23 at 5:51 PM
DateCompanyBrokerageAction
3/2/2021Silk Road MedicalCitigroupLower Price Target
11/11/2020Silk Road MedicalPiper SandlerBoost Price Target
10/12/2020Silk Road MedicalSVB LeerinkBoost Price Target
8/6/2020Silk Road MedicalStifel NicolausBoost Price Target
8/20/2019Silk Road MedicalArgusInitiated Coverage
4/29/2019Silk Road MedicalBank of AmericaInitiated Coverage
4/29/2019Silk Road MedicalJPMorgan Chase & Co.Initiated Coverage
4/29/2019Silk Road MedicalBMO Capital MarketsInitiated Coverage
4/1/2021PulmonxCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellInitiated Coverage
3/9/2021PulmonxMorgan StanleyBoost Price Target
3/9/2021PulmonxCanaccord GenuityBoost Price Target
3/3/2021PulmonxWells Fargo & CompanyBoost Price Target
3/30/2021Axonics Modulation TechnologiesNeedham & Company LLCBoost Price Target
1/26/2021Axonics Modulation TechnologiesRobert W. BairdBoost Price Target
11/5/2020Axonics Modulation TechnologiesTruistBoost Price Target
10/23/2020Axonics Modulation TechnologiesGuggenheimInitiated Coverage
3/17/2021Cardiovascular SystemsOppenheimerReiterated Rating
2/15/2021Cardiovascular SystemsAegisReiterated Rating
12/16/2020Cardiovascular SystemsNorthland SecuritiesBoost Price Target
7/17/2020Cardiovascular SystemsBarclaysInitiated Coverage
5/6/2020Cardiovascular SystemsLake Street CapitalLower Price Target
1/8/2021Inovio PharmaceuticalsBenchmarkLower Price Target
11/17/2020Inovio PharmaceuticalsRoth CapitalDowngrade
9/28/2020Inovio PharmaceuticalsMaxim GroupUpgrade
9/28/2020Inovio PharmaceuticalsCantor FitzgeraldDowngrade
9/9/2020Inovio PharmaceuticalsHC WainwrightReiterated Rating
(Data available from 4/11/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.